Graft survival rates from deceased donors aged 35 years or less among all primary pediatric kidney transplant recipients in the United States between 1996 and 2004 were retrospectively examined to de-termine the effect of HLA-DR mismatches on graft survival. Zero HLA-DR-mismatched kidneys had sta-tistically comparable 5-year graft survival (71%), to 1-DR-mismatched kidneys (69%) and 2-DR-mismatched kidneys (71%). When compared to donors less than 35 years of age, the relative rate of allograft failure was 1.32 (p = 0.0326) for donor age greater than or equal to age 35. There was no statistical increase in the odds of developing a panel-reactive antibody (PRA) greater than 30 % at the time of secondwaitlisting, based upon the degree of HLA-A...
BACKGROUND: Renal transplantation improves quality of life (QoL) and survival in children requiring ...
Background Pre-transplant donor-specific anti-human leucocyte antigen (HLA) antibodies (DSAs) are as...
BACKGROUND: Recently, the impact of human leukocyte antigen (HLA) mismatch (MM) on graft outcome has...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/74900/1/j.1600-6143.2008.02320.x.pd
Background. Even in the modern era of kidney transplantation with improved surgical techniques, immu...
Background. It has been suggested that recipient age may have an effect on renal graft survival due ...
Background Human leukocyte antigen (HLA) mismatches are known to influence graft survival in decease...
Purpose: The aim of this study was to identify factors impacting recipient sensitization rates and p...
The aim of this study was to evaluate the correlation between epitopic HLA mismatches and the risk o...
The development of donor-specific HLA antibodies (DSA) is associated with worse renal allograft surv...
Summary: In North America, about 50 % of all renal transplants done in children are from a living-re...
Background: Reports of HLA incompatible (HLAi) kidney transplant outcomes are inconclusive, especi...
Thesis (Master's)--University of Washington, 2014Background: The association between donor-recipient...
Item does not contain fulltextBACKGROUND: Evidence-based guidelines for pediatric renal transplantat...
PURPOSE: To retrospectively review our experience with pediatric renal transplantation and to compar...
BACKGROUND: Renal transplantation improves quality of life (QoL) and survival in children requiring ...
Background Pre-transplant donor-specific anti-human leucocyte antigen (HLA) antibodies (DSAs) are as...
BACKGROUND: Recently, the impact of human leukocyte antigen (HLA) mismatch (MM) on graft outcome has...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/74900/1/j.1600-6143.2008.02320.x.pd
Background. Even in the modern era of kidney transplantation with improved surgical techniques, immu...
Background. It has been suggested that recipient age may have an effect on renal graft survival due ...
Background Human leukocyte antigen (HLA) mismatches are known to influence graft survival in decease...
Purpose: The aim of this study was to identify factors impacting recipient sensitization rates and p...
The aim of this study was to evaluate the correlation between epitopic HLA mismatches and the risk o...
The development of donor-specific HLA antibodies (DSA) is associated with worse renal allograft surv...
Summary: In North America, about 50 % of all renal transplants done in children are from a living-re...
Background: Reports of HLA incompatible (HLAi) kidney transplant outcomes are inconclusive, especi...
Thesis (Master's)--University of Washington, 2014Background: The association between donor-recipient...
Item does not contain fulltextBACKGROUND: Evidence-based guidelines for pediatric renal transplantat...
PURPOSE: To retrospectively review our experience with pediatric renal transplantation and to compar...
BACKGROUND: Renal transplantation improves quality of life (QoL) and survival in children requiring ...
Background Pre-transplant donor-specific anti-human leucocyte antigen (HLA) antibodies (DSAs) are as...
BACKGROUND: Recently, the impact of human leukocyte antigen (HLA) mismatch (MM) on graft outcome has...